Exozymes CCO converts 19,612 RSUs to shares

Rhea-AI Filing Summary

EXOZYMES INC. (EXOZ) reported that Chief Commercial Officer Damien Alan Perriman exercised restricted stock units into common shares. On August 19, 2026, he converted 19,612 RSUs into 19,612 shares of common stock from a January 14, 2026 grant of 62,759 RSUs. Following these transactions, he directly holds 28,499 common shares and 43,147 RSUs that continue to vest periodically.

Insider Trade Summary

19,612 shares exercised/converted

Exercise 2 txns

Insider Perriman Damien Alan

Role Chief Commercial Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit F1, F2	19,612	$0.00	$0.00
Exercise	Common Stock F1	19,612	--	--

Holdings After Transaction: Restricted Stock Unit — 43,147 contracts (Direct); Common Stock — 28,499 shares (Direct)

Footnotes (2)

1. F1. The RSU convert on a one-for-one basis.
2. F2. On January 14, 2026, the reporting person was granted an aggregate of 62,759 RSUs, vesting periodically. The first vesting was August 19, 2026, in the amount of 19,612 shares of common stock.

Key Figures

RSUs exercised: 19,612 RSUs Common shares acquired: 19,612 shares Common shares held after transaction: 28,499 shares +2 more

5 metrics

RSUs exercised 19,612 RSUs Converted into common stock on August 19, 2026

Common shares acquired 19,612 shares Common stock received from RSU conversion on August 19, 2026

Common shares held after transaction 28,499 shares Direct ownership of Damien Alan Perriman following the August 19, 2026 transactions

RSUs outstanding after transaction 43,147 RSUs Remaining RSUs after 19,612 vested from the 62,759-unit grant

Total RSU grant 62,759 RSUs RSUs granted to Damien Alan Perriman on January 14, 2026

Key Terms

Restricted Stock Unit, Exercise or conversion of derivative security, vesting

3 terms

Restricted Stock Unit financial

"The RSU convert on a one-for-one basis."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Exercise or conversion of derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

vesting financial

"vesting periodically. The first vesting was August 19, 2026"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did EXOZ (EXOZYMES INC.) disclose for Damien Perriman?

The filing shows Damien Alan Perriman exercised 19,612 restricted stock units into 19,612 shares of common stock on August 19, 2026, as part of a previously granted RSU award.

How many EXOZ common shares does Damien Perriman hold after this Form 4?

After the reported transactions, Damien Alan Perriman directly holds 28,499 shares of EXOZ common stock, according to the Form 4 data.

How many restricted stock units remain for Damien Perriman at EXOZ (EXOZ)?

Following the August 19, 2026 vesting, Damien Alan Perriman has 43,147 restricted stock units (RSUs) remaining from his RSU award, as reported in the filing.

What was the size and date of Damien Perriman’s RSU grant at EXOZ?

On January 14, 2026, Damien Alan Perriman was granted an aggregate of 62,759 RSUs, vesting periodically. The first vesting occurred on August 19, 2026 for 19,612 shares of common stock.

Did the EXOZ Form 4 involve a market sale or purchase by Damien Perriman?

The Form 4 reports an exercise and conversion of RSUs into common stock, not an open-market sale or purchase. One transaction disposes of derivative RSUs while the other acquires the corresponding common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/25/2026 - 07:17 PM EDT Accepted by SEC EDGAR 08/25/2026 - 07:16 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Perriman Damien Alan

(Last) (First) (Middle)

750 ROYAL OAKS DRIVE /106

(Street)

MONROVIA CALIFORNIA 91016

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EXOZYMES INC. [ EXOZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Commercial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/19/2026		M		19,612	A	(1)	28,499	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	08/19/2026		M			19,612	(2)	(2)	Common Stock	19,612	$0	43,147	D

Explanation of Responses:

1. The RSU convert on a one-for-one basis.

2. On January 14, 2026, the reporting person was granted an aggregate of 62,759 RSUs, vesting periodically. The first vesting was August 19, 2026, in the amount of 19,612 shares of common stock.

	/s/ Damien Perriman	08/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)